OverviewSuggest Edit

EdiGENE is a biotech company that develops therapeutics using its proprietary technology CRISPR-GNDM (guide nucleotide-directed modulation) for the treatment of genetic disorders. The Company’s technology platform normalizes levels of gene expression without cutting the DNA or RNA.

TypePrivate
Founded2015
HQCambridge, MA, US
Websiteedigene.com

Recent NewsAll News

Latest Updates

Employees (est.) (Sept 2021)43(+11%)
Cybersecurity ratingCMore

EdiGENE Office Locations

EdiGENE has an office in Cambridge
Cambridge, MA, US (HQ)
F18, Riverview II, 245 First St
Show all (1)

EdiGENE Financials and Metrics

Summary Metrics

Founding Date

2015

EdiGENE total Funding

$143.5 m

EdiGENE latest funding size

$22 m

Time since last funding

5 months ago

EdiGENE investors

EdiGENE's latest funding round in April 2021 was reported to be $22 m. In total, EdiGENE has raised $143.5 m
Show all financial metrics

EdiGENE Cybersecurity Score

Cybersecurity ratingPremium dataset

C

77/100

SecurityScorecard logo

EdiGENE Online and Social Media Presence

Embed Graph

EdiGENE News and Updates

Chinese biotech firm EdiGene nabs $67m from Sequoia, IDG, others

The Series B round was led by Chinese healthcare-focused private equity fund 3H Health. The post Chinese biotech firm EdiGene nabs $67m from Sequoia, IDG, others appeared first on DealStreetAsia.

EdiGENE Frequently Asked Questions

  • When was EdiGENE founded?

    EdiGENE was founded in 2015.

  • How many employees does EdiGENE have?

    EdiGENE has 43 employees.

  • Who are EdiGENE competitors?

    Competitors of EdiGENE include Coda Biotherapeutics, Alerion and Pluristem Therapeutics.

  • Where is EdiGENE headquarters?

    EdiGENE headquarters is located at F18, Riverview II, 245 First St, Cambridge.

  • Where are EdiGENE offices?

    EdiGENE has an office in Cambridge.

  • How many offices does EdiGENE have?

    EdiGENE has 1 office.